A carregar...

Efficacy of ethinylestradiol 20 µg/drospirenone 3 mg in a flexible extended regimen in women with moderate-to-severe primary dysmenorrhoea: an open-label, multicentre, randomised, controlled study

OBJECTIVES: The aim of this Phase III, multicentre, open-label, randomised study was to compare the efficacy and safety of ethinylestradiol (EE)/drospirenone (DRSP) in a new flexible extended regimen that allowed the management of intracyclic (breakthrough) bleeding (MIB) with that of EE/DRSP in a c...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Strowitzki, Thomas, Kirsch, Bodo, Elliesen, Jörg
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Group 2012
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3353877/
https://ncbi.nlm.nih.gov/pubmed/22454006
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jfprhc-2011-100225
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!